← All Sponsors
SPONSOR

University of Rochester

Total Trials
17
Recruiting
17
Phases
Phase 2, Phase 4, EARLY_Phase 1

University of Rochester is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Colorectal Cancer Metastatic, Cancer Related Cognitive Difficulties, Breast Cancer Female, Vestibular Disease.

The trial portfolio spans Phase 2, Phase 4, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Rochester

How many clinical trials has University of Rochester sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by University of Rochester, of which 17 are actively recruiting participants. These trials cover conditions including Colorectal Cancer Metastatic, Cancer Related Cognitive Difficulties, Breast Cancer Female. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Rochester research focus on?
University of Rochester clinical trials span Colorectal Cancer Metastatic, Cancer Related Cognitive Difficulties, Breast Cancer Female, Vestibular Disease, Recurrent Prostate Cancer After Surgery, and additional conditions. The research pipeline includes Phase 2, Phase 4, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Rochester clinical trial?
To participate in a University of Rochester trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Rochester trials with current recruitment status updated daily.

Clinical Trials by University of Rochester

NCT05248581
Recruiting

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Colorectal Cancer Metastatic
NCT03137095
Recruiting

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

Cancer Related Cognitive Difficulties
NCT04142697
Recruiting

Human Visual and Vestibular Motion Perception Study

Vestibular Disease
NCT05946824 Phase 2
Recruiting

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Recurrent Prostate Cancer After Surgery
NCT07260864
Recruiting

Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia

Fibromyalgia (FM)
NCT05034432 Phase 4
Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Arrythmia
NCT07356310
Recruiting

Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry

Breathing
NCT07430735
Recruiting

BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber

Dry Eye Disease (DED)
NCT07010705
Recruiting

Digital Measures for Clinical Trial Endpoints in Huntington's Disease

Huntington Disease
NCT07290387
Recruiting

Tele-Savvy for Latino Caregivers

Alzheimer Disease
NCT07630402
Recruiting

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Breast Cancer With Low to Intermediate HER2 Expression
NCT05285683 Phase 2
Recruiting

The Role of Brain Dopamine in Chronic Pain

Chronic Pain
NCT03706027
Recruiting

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Lung Cancer
NCT05530655 EARLY_Phase 1
Recruiting

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

Prostate Cancer
NCT05272254 Phase 2
Recruiting

Povidone Iodine Efficacy Study

Early Childhood Caries
NCT06614322 Phase 2
Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Painful Peripheral Neuropathy
NCT07134777
Recruiting

Mechanisms of Visual Restoration After Occipital Stroke

Cortical Blindness
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology